Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Soedarsono Soedarsono"'
Autor:
Soedarsono Soedarsono, MD, PhD, Sri Sarwosih Indah Marthaty, MD, Caesar Rozaq Auditiawan, MD, Anita Widyoningroem, MD
Publikováno v:
Radiology Case Reports, Vol 19, Iss 8, Pp 3162-3169 (2024)
The complication of hydropneumothorax and colovesical fistula is rare, especially in patients with tuberculosis (TB) and COVID-19. This particular situation poses a management difficulty, and can significantly threaten the patient's life without a cl
Externí odkaz:
https://doaj.org/article/b14e1a6490b542eaa991f558142644cc
Autor:
Deby Kusumaningrum, Ni Made Mertaniasih, Soedarsono Soedarsono, Rosy Setiawati, Canti Permata Pradipta
Publikováno v:
International Journal of Mycobacteriology, Vol 13, Iss 2, Pp 152-157 (2024)
Objective: GeneXpert Mycobacterium tuberculosis/rifampicin (MTB/RIF) is a conceptually helpful tool for establishing tuberculosis (TB) disease. Negative results from the GeneXpert test do not exclude the possibility of diagnosing non-tuberculous myco
Externí odkaz:
https://doaj.org/article/b639d407dbbf4077bc110275c6132a6c
Autor:
Soedarsono Soedarsono, Ni Made Mertaniasih, Tutik Kusmiati, Ariani Permatasari, Susi Subay, Suko Hari Adiono
Publikováno v:
International Journal of Mycobacteriology, Vol 13, Iss 2, Pp 140-146 (2024)
Background: Bedaquiline is one of the core drugs used to treat multidrug-resistant TB (MDR-TB). Delamanid is one of the companion drugs in group C which is used to complete the treatment regimen when drugs in groups A and B can not be used. This stud
Externí odkaz:
https://doaj.org/article/e3ebac929b1342199b6e6390cca0eaa3
Publikováno v:
Perspectives in Clinical Research, Vol 15, Iss 2, Pp 89-93 (2024)
Background: Bedaquiline and delamanid have been included in the individualized treatment regimen (ITR) to treat patients with drug-resistant tuberculosis (DR-TB). Objective: The objective of this study is to compare the effectiveness of sputum cultur
Externí odkaz:
https://doaj.org/article/57c8d30027d64e088344e7b7f14821cd
Autor:
Anindya Zalfaa Kusuma Dewi, Ronald Pratama A., Dody Taruna, Irmawati M. Dikman, Soedarsono Soedarsono, Yelvi Levani
Publikováno v:
Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya, Vol 8, Iss 02 (2024)
Tuberculosis (TB) is the most common opportunistic infection in people living with HIV/AIDS in Indonesia, and HIV infection promotes Mycobacterium tuberculosis infection. In ODHIV, the probability of contracting TB is 10% per year. According to the I
Externí odkaz:
https://doaj.org/article/7b8f4543f49f468fa4d03914a0b06066
Publikováno v:
Acta Medica Indonesiana, Vol 55, Iss 4 (2023)
Background: The use of bedaquiline has been reported to minimize the number of lost to follow-up and fewer rejections from the patients. This study is the first to depict the use of bedaquiline. It aims to provide information related to the profile o
Externí odkaz:
https://doaj.org/article/1157ee51f9ae4f63b6a452b373608d67
Publikováno v:
International Journal of Mycobacteriology, Vol 12, Iss 3, Pp 241-247 (2023)
Background: Bedaquiline is a core drug with an optimized background regimen for treating drug-resistant tuberculosis (DR-TB) patients. One of the adverse effects of bedaquiline is QT-corrected (QTc) interval prolongation. TB patients with diabetes me
Externí odkaz:
https://doaj.org/article/e7340dc588d846c4880d24ef4f8685bd
Publikováno v:
Asian Pacific Journal of Tropical Medicine, Vol 16, Iss 4, Pp 169-175 (2023)
Objective: To evaluate early efficacy of sputum conversion within 6 months of individual regimens containing bedaquiline in patients with drug resistant tuberculosis. Methods: We conducted a retrospective study among patients with drug resistant tube
Externí odkaz:
https://doaj.org/article/d719136e2d454b369ba9a9fbfc26d454
Publikováno v:
International Journal of Mycobacteriology, Vol 12, Iss 1, Pp 1-9 (2023)
Background: Drug-resistant tuberculosis (DR-TB) is a public health concern that is difficult to treat, requiring long and complex treatment with highly effective drugs. Bedaquiline and/or delamanid have already shown promising outcomes in patients wi
Externí odkaz:
https://doaj.org/article/6e0e7954606f49659c4a606219fe560b
Autor:
Muhamad Frendy Setyawan, Ni Made Mertaniasih, Budi Utomo, Soedarsono Soedarsono, I Made Dwi Mertha Adnyana, Dwinka Syafira Eljatin, Lesty Helda Marsel Sumah, Citra Al Karina, Zakiyathun Nuha
Publikováno v:
National Journal of Community Medicine, Vol 14, Iss 05 (2023)
Background: Pulmonary tuberculosis is still a public health problem, and surveillance data analysis has not been done much. Recently a global pandemic of COVID-19 has the potential in disturbing TB elimination programs and treatment. This study aims
Externí odkaz:
https://doaj.org/article/ca3fd2a972c34772bf57fcbe7f478477